Connect Biopharma Holdings Limited (CNTB)
Total Valuation
CNTB has a market cap or net worth of $44.06 million. The enterprise value is -$88.58 million.
| Market Cap | 44.06M |
| Enterprise Value | -88.58M |
Important Dates
The last earnings date was Tuesday, September 12, 2023, after market close.
| Earnings Date | Sep 12, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
CNTB has 55.07 million shares outstanding.
| Shares Outstanding | 55.07M |
| Owned by Insiders (%) | 39.86% |
| Owned by Institutions (%) | 39.87% |
| Float | 18.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.26, with a Debt / Equity ratio of 0.00.
| Current Ratio | 9.26 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3,834.35 |
Financial Efficiency
Return on equity (ROE) is -51.50% and return on invested capital (ROIC) is -144.50%.
| Return on Equity (ROE) | -51.50% |
| Return on Assets (ROA) | -46.50% |
| Return on Capital (ROIC) | -144.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$839,412 |
| Employee Count | 100 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CNTB has paid $239,609 in taxes.
| Income Tax | 239,609 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.36% in the last 52 weeks. The beta is -0.45, so CNTB's price volatility has been lower than the market average.
| Beta (1Y) | -0.45 |
| 52-Week Price Change | -38.36% |
| 50-Day Moving Average | 0.86 |
| 200-Day Moving Average | 1.02 |
| Relative Strength Index (RSI) | 46.29 |
| Average Volume (30 Days) | 31,219 |
Short Selling Information
| Short Interest | 7,490 |
| Short Previous Month | 8,671 |
| Short % of Shares Out | 6.58% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.82 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -85.91M |
| Pretax Income | -83.02M |
| Net Income | -83.94M |
| EBITDA | n/a |
| EBIT | -83.00M |
| Earnings Per Share (EPS) | -$1.52 |
Balance Sheet
The company has $130.24 million in cash and $588,268 in debt, giving a net cash position of $129.65 million or $2.35 per share.
| Cash & Cash Equivalents | 130.24M |
| Total Debt | 588,268 |
| Net Cash | 129.65M |
| Net Cash Per Share | $2.35 |
| Equity / Book Value | 127.37M |
| Book Value Per Share | 2.31 |
| Working Capital | 122.00M |
Cash Flow
In the last 12 months, operating cash flow was -$76.81 million and capital expenditures -$2.74 million, giving a free cash flow of -$79.56 million.
| Operating Cash Flow | -76.81M |
| Capital Expenditures | -2.74M |
| Free Cash Flow | -79.56M |
| FCF Per Share | -$1.45 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CNTB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -204.37% |
| FCF Yield | -193.70% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.04% |
| Shareholder Yield | -2.04% |
Analyst Forecast
The average price target for CNTB is $6.00, which is 650.00% higher than the current price. The consensus rating is "Buy".
| Price Target | $6.00 |
| Price Target Difference | 650.00% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |